|Articles|November 9, 2021
- Pharmaceutical Executive-11-01-2021
- Volume 41
- Issue 11
Pharmaceutical Executive, November 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive November 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 4 years ago
In It For the Long-Haul: Planning for the Future of COVID-19over 4 years ago
Turning the Corner: A New Era of Pharma Sales Comes Into Viewover 4 years ago
The New COVID Workforce: Keeping Pharma Strong Through Adversityover 4 years ago
Crafting Curesover 4 years ago
Could 2022 Prove to Be Better Year for Biotech Companies?over 4 years ago
COVID and the Data Talent Turnaboutover 4 years ago
EU MEPs Arrive At Crossroads in Cancer Strategyover 4 years ago
Pharm Exec at 40 (2015-2018)Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5

